Record Information |
---|
Version | 2.0 |
---|
Created at | 2023-01-12 20:00:39 UTC |
---|
Updated at | 2024-09-03 04:15:45 UTC |
---|
NP-MRD ID | NP0331438 |
---|
Natural Product DOI | https://doi.org/10.57994/0386 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Actinomycin V |
---|
Description | ACTINOMYCIN V belongs to the class of organic compounds known as cyclic depsipeptides. These are natural or synthetic compounds having sequences of amino and hydroxy carboxylic acid residues (usually α-amino and α-hydroxy acids) connected in a ring. The residues are commonly but not necessarily regularly alternating. Actinomycin V was first documented in 2009 (PMID: 19137288). Based on a literature review a significant number of articles have been published on ACTINOMYCIN V (PMID: 31305144) (PMID: 32807803) (PMID: 34822470) (PMID: 33236226) (PMID: 32824227) (PMID: 31601054). |
---|
Structure | CC(C)[C@H]1NC(=O)[C@@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@H]2[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]3CC(=O)CN3C(=O)[C@H](NC2=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O InChI=1S/C62H84N12O17/c1-26(2)42-59(85)73-21-17-18-36(73)57(83)69(13)24-38(76)71(15)48(28(5)6)61(87)89-32(11)44(55(81)65-42)67-53(79)35-20-19-30(9)51-46(35)64-47-40(41(63)50(78)31(10)52(47)91-51)54(80)68-45-33(12)90-62(88)49(29(7)8)72(16)39(77)25-70(14)58(84)37-22-34(75)23-74(37)60(86)43(27(3)4)66-56(45)82/h19-20,26-29,32-33,36-37,42-45,48-49H,17-18,21-25,63H2,1-16H3,(H,65,81)(H,66,82)(H,67,79)(H,68,80)/t32-,33-,36+,37+,42-,43-,44+,45+,48+,49+/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C62H84N12O17 |
---|
Average Mass | 1269.4210 Da |
---|
Monoisotopic Mass | 1268.60774 Da |
---|
IUPAC Name | Not Available |
---|
Traditional Name | Not Available |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(C)[C@H]1NC(=O)[C@@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@H]2[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]3CC(=O)CN3C(=O)[C@H](NC2=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O |
---|
InChI Identifier | InChI=1S/C62H84N12O17/c1-26(2)42-59(85)73-21-17-18-36(73)57(83)69(13)24-38(76)71(15)48(28(5)6)61(87)89-32(11)44(55(81)65-42)67-53(79)35-20-19-30(9)51-46(35)64-47-40(41(63)50(78)31(10)52(47)91-51)54(80)68-45-33(12)90-62(88)49(29(7)8)72(16)39(77)25-70(14)58(84)37-22-34(75)23-74(37)60(86)43(27(3)4)66-56(45)82/h19-20,26-29,32-33,36-37,42-45,48-49H,17-18,21-25,63H2,1-16H3,(H,65,81)(H,66,82)(H,67,79)(H,68,80)/t32-,33-,36+,37+,42-,43-,44+,45+,48+,49+/m1/s1 |
---|
InChI Key | GQZJMUMSSGCVFS-IRFLANFNSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
ROESY NMR | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | guangxzh@sina.com | Not Available | Not Available | 2023-01-12 | View Spectrum | NOESY NMR | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | guangxzh@sina.com | Not Available | Not Available | 2023-01-12 | View Spectrum | HMBC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | guangxzh@sina.com | Not Available | Not Available | 2023-01-12 | View Spectrum | COSY NMR | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | guangxzh@sina.com | Not Available | Not Available | 2023-01-12 | View Spectrum | HSQC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | guangxzh@sina.com | Not Available | Not Available | 2023-01-12 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | guangxzh@sina.com | Not Available | Not Available | 2023-01-12 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | guangxzh@sina.com | Not Available | Not Available | 2023-01-12 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | guangxzh@sina.com | Not Available | Not Available | 2023-01-12 | View Spectrum |
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
| Chemical Shift Submissions |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600, CD3OD, simulated) | Not Available | Not Available | Not Available | 2024-05-11 | View Spectrum |
| Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
antibioticus H41-55 | | |
|
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as cyclic depsipeptides. These are natural or synthetic compounds having sequences of amino and hydroxy carboxylic acid residues (usually α-amino and α-hydroxy acids) connected in a ring. The residues are commonly but not necessarily regularly alternating. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Peptidomimetics |
---|
Sub Class | Depsipeptides |
---|
Direct Parent | Cyclic depsipeptides |
---|
Alternative Parents | |
---|
Substituents | - Cyclic depsipeptide
- Macrolide lactam
- Phenoxazine
- Macrolactam
- Alpha-amino acid ester
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid or derivatives
- Dicarboxylic acid or derivatives
- Benzenoid
- Pyrrolidone
- 3-pyrrolidone
- Heteroaromatic compound
- Vinylogous amide
- Pyrrolidine
- Tertiary carboxylic acid amide
- Amino acid or derivatives
- Carboxamide group
- Carboxylic acid ester
- Ketone
- Lactam
- Lactone
- Cyclic ketone
- Secondary carboxylic acid amide
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Carboxylic acid derivative
- Hydrocarbon derivative
- Carbonyl group
- Organic oxygen compound
- Organic oxide
- Organic nitrogen compound
- Amine
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Lu DD, Ren JW, Du QQ, Song YJ, Lin SQ, Li X, Li EW, Xie WD: p-Terphenyls and actinomycins from a Streptomyces sp. associated with the larva of mud dauber wasp. Nat Prod Res. 2021 Jun;35(11):1869-1873. doi: 10.1080/14786419.2019.1639177. Epub 2019 Jul 15. [PubMed:31305144 ]
- Silva LJ, Crevelin EJ, Souza DT, Lacerda-Junior GV, de Oliveira VM, Ruiz ALTG, Rosa LH, Moraes LAB, Melo IS: Actinobacteria from Antarctica as a source for anticancer discovery. Sci Rep. 2020 Aug 17;10(1):13870. doi: 10.1038/s41598-020-69786-2. [PubMed:32807803 ]
- Jiang S, Zhang E, Ruan H, Ma J, Zhao X, Zhu Y, Xie X, Han N, Li J, Zhang H, Xie W, Li X: Actinomycin V Induces Apoptosis Associated with Mitochondrial and PI3K/AKT Pathways in Human CRC Cells. Mar Drugs. 2021 Oct 22;19(11):599. doi: 10.3390/md19110599. [PubMed:34822470 ]
- Overacker RD, Plitzko B, Loesgen S: Biolayer interferometry provides a robust method for detecting DNA binding small molecules in microbial extracts. Anal Bioanal Chem. 2021 Feb;413(4):1159-1171. doi: 10.1007/s00216-020-03079-5. Epub 2020 Nov 25. [PubMed:33236226 ]
- Jia FJ, Han Z, Ma JH, Jiang SQ, Zhao XM, Ruan H, Xie WD, Li X: Involvement of Reactive Oxygen Species in the Hepatorenal Toxicity of Actinomycin V In Vitro and In Vivo. Mar Drugs. 2020 Aug 15;18(8):428. doi: 10.3390/md18080428. [PubMed:32824227 ]
- Lin SQ, Jia FJ, Zhang CY, Liu FY, Ma JH, Han Z, Xie WD, Li X: Actinomycin V Suppresses Human Non-Small-Cell Lung Carcinoma A549 Cells by Inducing G2/M Phase Arrest and Apoptosis via the p53-Dependent Pathway. Mar Drugs. 2019 Oct 9;17(10):572. doi: 10.3390/md17100572. [PubMed:31601054 ]
- Lin S, Zhang C, Liu F, Ma J, Jia F, Han Z, Xie W, Li X: Actinomycin V Inhibits Migration and Invasion via Suppressing Snail/Slug-Mediated Epithelial-Mesenchymal Transition Progression in Human Breast Cancer MDA-MB-231 Cells In Vitro. Mar Drugs. 2019 May 24;17(5):305. doi: 10.3390/md17050305. [PubMed:31137656 ]
- Liu CW, Lu YY, Yang ZZ, Xing YY, Xi T: Rapid screening and characterization of metabolites from a marine-derived actinomycete by high-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 2010 Dec 15;24(23):3413-8. doi: 10.1002/rcm.4744. [PubMed:21072796 ]
- Singh V, Khan M, Khan S, Tripathi CK: Optimization of actinomycin V production by Streptomyces triostinicus using artificial neural network and genetic algorithm. Appl Microbiol Biotechnol. 2009 Feb;82(2):379-85. doi: 10.1007/s00253-008-1828-0. Epub 2009 Jan 10. [PubMed:19137288 ]
- Liu T, Xu T, Hu C, Sun D, Zhou G: Hemiactinomycin, an undescribed intermediate of actinomycin biosynthesis from an actinomycetes strain Streptomyces antibioticus H41-55. Nat Prod Res. 2024 May;38(9):1577-1582. doi: 10.1080/14786419.2022.2161541. Epub 2022 Dec 23. [PubMed:36564053 ]
|
---|